+

WO2003004663A2 - Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees - Google Patents

Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees Download PDF

Info

Publication number
WO2003004663A2
WO2003004663A2 PCT/EP2002/006560 EP0206560W WO03004663A2 WO 2003004663 A2 WO2003004663 A2 WO 2003004663A2 EP 0206560 W EP0206560 W EP 0206560W WO 03004663 A2 WO03004663 A2 WO 03004663A2
Authority
WO
WIPO (PCT)
Prior art keywords
gene
codes
threonine
microorganisms
genes
Prior art date
Application number
PCT/EP2002/006560
Other languages
English (en)
Other versions
WO2003004663A3 (fr
Inventor
Mechthild Rieping
Original Assignee
Degussa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10132946A external-priority patent/DE10132946A1/de
Application filed by Degussa Ag filed Critical Degussa Ag
Priority to US10/481,746 priority Critical patent/US7172883B2/en
Priority to EP02730294A priority patent/EP1404821B1/fr
Priority to DE60234444T priority patent/DE60234444D1/de
Priority to AT02730294T priority patent/ATE449167T1/de
Priority to DK02730294.2T priority patent/DK1404821T3/da
Priority to AU2002302642A priority patent/AU2002302642A1/en
Publication of WO2003004663A2 publication Critical patent/WO2003004663A2/fr
Publication of WO2003004663A3 publication Critical patent/WO2003004663A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine

Definitions

  • This invention relates to a process for the preparation of L-amino acids, in particular L-threonine, using strains of the Enterobacteriaceae family in which at least one or more of the genes chosen from the group consisting of ahpC and ahpp is (are) enhanced.
  • L-Amino acids in particular L-threonine, are used in human medicine and in the pharmaceuticals industry, in the foodstuffs industry and very particularly in animal nutrition.
  • Methods of mutagenesis, selection and mutant selection are used to improve the output properties of these microorganisms.
  • Strains which are resistant to antimetabolites such as e.g. the threonine analogue ⁇ - amino- ⁇ -hydroxyvaleric acid (AHV) , or are auxotrophic for metabolites of regulatory importance and produce L-amino acid, such as e.g. L-threonine, are obtained in this manner.
  • Methods of the recombinant DNA technique have also been employed for some years for improving the strain of strains of the Enterobacteriaceae family which produce L- amino acids, by amplifying individual amino acid biosynthesis genes and investigating the effect on the production.
  • the object of the invention is to provide new measures for improved fermentative preparation of L-amino acids, in particular L-threonine.
  • the invention provides a process for the preparation of L- amino acids, in particular L-threonine, using microorganisms of the Enterobacteriaceae family which in particular already produce L-amino acids and in which at least one or more of the nucleotide sequence (s) which code(s) for the ahpC and ahpF genes is (are) enhanced.
  • L-amino acids or a ino acids are mentioned in the following, this means one or more amino acids, including their salts, chosen from the group consisting of L- asparagine, L-threonine, L-serine, L-glutamate, L-glycine, L-alanine, L-cysteine, L-valine, L-methionine, L- isoleucine, L-leucine, L-tyrosine, L-phenylalanine, L- histidine, L-lysine, L-tryptophan and L-arginine.
  • L- Threonine is particularly preferred.
  • enhancement in this connection describes the increase in the intracellular activity of one or more enzymes or proteins in a microorganism which are coded by the corresponding DNA, for example by increasing the number of copies of the gene or genes, using a potent promoter or a gene or allele which codes for a corresponding enzyme or protein with a high activity, and optionally combining these measures .
  • the activity or concentration of the corresponding protein is in general increased by at least 10%, 25%, 50%, 75%, 100%, 150%, 200%, 300%, 400% or 500%, up to a maximum of 1000% or 2000%, based on that of the wild-type protein or the activity or concentration of the protein in the starting microorganis .
  • the microorganisms which the present invention provides can produce L-amino acids from glucose, sucrose, lactose, fructose, maltose, molasses, optionally starch, optionally cellulose or from glycerol and ethanol .
  • They are representatives of the Enterobacteriaceae family chosen from the genera Escherichia, Erwinia, Providencia and Serratia.
  • the genera Escherichia and Serratia are preferred.
  • the species Escherichia coli and of the genus Serratia the species Serratia marcescens are to be mentioned in particular.
  • Suitable strains, which produce L-threonine in particular, of the genus Escherichia, in particular of the species Escherichia coli are, for example
  • Suitable L-threonine-producing strains of the genus Serratia in particular of the species Serratia marcescens, are, for example
  • Strains from the Enterobacteriaceae family which produce L- threonine preferably have, inter alia, one or more genetic or phenotypic features chosen from the group consisting of: resistance to -amino- ⁇ -hydroxyvaleric acid, resistance to thialysine, resistance to ethionine, resistance to ⁇ - methylserine, resistance to diaminosuccinic acid, resistance to -aminobutyric acid, resistance to borrelidin, resistance to rifampicin, resistance to valine analogues, such as, for example, valine hydroxamate, resistance to purine analogues, such as, for example, 6- dimethylaminopurine, a need for L-methionine, optionally a partial and compensatable need for L-isoleucine, a need for meso-diaminopimelic acid, auxotrophy in respect of threonine-containing dipeptides, resistance to L-threonine, resistance to L-
  • microorganisms of the Enterobacteriaceae family produce L-amino acids, in particular L-threonine, in an improved manner after enhancement, in particular over-expression, of at least one or more of the genes chosen from the group consisting of ahpC and ahpF.
  • Endogenous genes or “endogenous nucleotide sequences” are understood as meaning the genes or nucleotide sequences present in the population of a species .
  • the nucleotide sequences of the genes of Escherichia coli belong to the . prior art and can also be found in the genome sequence of Escherichia coli published by Blattner et al . (Science 277: 1453-1462 (1997)).
  • ahpC gene Description: C22 subunit of alkyl hydroperoxide reductase; detoxification of hydroperoxides
  • ahpF gene Description: F52a subunit of alkyl hydroperoxide reductase; detoxification of hydroperoxides Reference: Ferrante et al . ; Proceedings of the National Academy of Sciences USA 92(17) : 7617-7621 (1995) Poole and Ellis; Biochemistry 35(1): 56-64 (1996) Poole et al . ; European Journal of Biochemistry 267(20): 6126-6133 (2000)
  • nucleic acid sequences can be found in the databanks of the National Center for Biotechnology Information (NCBI) of the National Library of Medicine (Bethesda, MD, USA) , the nucleotide sequence databank of the European Molecular Biologies Laboratories (EMBL, Heidelberg, Germany or Cambridge, UK) or the DNA databank of Japan (DDBJ, Mishi a, Japan) .
  • NCBI National Center for Biotechnology Information
  • EMBL European Molecular Biologies Laboratories
  • DDBJ Mishi a, Japan
  • Alleles of at least one or more of the genes chosen from the group consisting of ahpC and ahpF which result from the degeneracy of the genetic code or due to "sense mutations" of neutral function can furthermore be used.
  • expression of the genes or the catalytic properties of the proteins can be increased.
  • the two measures can optionally be combined.
  • the number of copies of the corresponding genes can be increased, or the promoter and regulation region or the ribosome binding site upstream of the structural gene can be mutated.
  • Expression cassettes which are incorporated upstream of the structural gene act in the same way.
  • inducible promoters it is additionally possible to increase the expression in the course of fermentative L-threonine production.
  • the expression is likewise improved by measures to prolong the life of the m-RNA.
  • the enzyme activity is also enhanced by preventing the degradation of the enzyme protein.
  • the genes or gene constructs can either be present in plasmids with a varying number of copies, or can be integrated and amplified in the chromosome. Alternatively, an over-expression of the genes in question can furthermore be achieved by changing the composition of the media and the culture procedure.
  • Plasmid vectors which are capable of replication in Enterobacteriaceae such as e.g. cloning vectors derived from pACYCl84 (Bartolome et al . ; Gene 102: 75-78 (1991)), pTrc99A (Amann et al . ; Gene 69: 301-315 (1988)) or pSClOl derivatives (Vocke and Bastia, Proceedings of the National Academy of Sciences USA 80(21): 6557-6561 (1983)) can be used.
  • cloning vectors derived from pACYCl84 Bartolome et al . ; Gene 102: 75-78 (1991)
  • pTrc99A Amann et al . ; Gene 69: 301-315 (1988)
  • pSClOl derivatives Vocke and Bastia, Proceedings of the National Academy of Sciences USA 80(21): 6557-6561 (1983)
  • a strain transformed with a plasmid vector wherein the plasmid vector carries at least one or more of the genes chosen from the group consisting of ahpC and ahpF or nucleotide sequences which code for them, can be employed in a process according to the invention.
  • L- amino acids in particular L-threonine
  • strains of the Enterobacteriaceae family to enhance one or more enzymes of the known threonine biosynthesis pathway or enzymes of anaplerotic metabolism or enzymes for the production of reduced nicotinamide adenine dinucleotide phosphate, in addition to the enhancement of one or more of the genes chosen from the group consisting of ahpC and ahpF.
  • L- amino acids in particular L-threonine
  • L-threonine in addition to the enhancement of one or more of the genes chosen from the group consisting of ahpC and ahpF, for one or more of the genes chosen from the group consisting of • the tdh gene which codes for threonine dehydrogenase (Journal of Bacteriology 169: 4716-4721 (1987)),
  • Attenuation in this connection describes the reduction or elimination of the intracellular activity of one or more enzymes (proteins) in a microorganism which are coded by the corresponding DNA, for example by using a weak promoter or a gene or allele which codes for a corresponding enzyme with a low activity or inactivates the corresponding enzyme (protein) or gene, and optionally combining these measures.
  • the activity or concentration of the corresponding protein is in general reduced to 0 to 75%, 0 to 50%, 0 to 25%, 0 to 10% or 0 to 5% of the activity or concentration of the wild-type protein or of the activity or concentration of the protein in the starting microorganism.
  • L- amino acids in particular L-threonine
  • L-threonine in addition to the enhancement of one or more of the genes chosen from the group consisting of ahpC and ahpF, to eliminate undesirable side reactions
  • microorganisms produced according to the invention can be cultured in the batch process (batch culture) , the fed batch (feed process) or the repeated fed batch process
  • Sugars and carbohydrates such as e.g. glucose, sucrose, lactose, fructose, maltose, molasses, starch and optionally cellulose, oils and fats, such as e.g. soya oil, sunflower oil, groundnut oil and coconut fat, fatty acids, such as e.g. palmitic acid, stearic acid and linoleic acid, alcohols, such as e.g. glycerol and ethanol, and organic acids, such as e.g. acetic acid, can be used as the source of carbon. These substances can be used individually or as a mixture.
  • oils and fats such as e.g. soya oil, sunflower oil, groundnut oil and coconut fat
  • fatty acids such as e.g. palmitic acid, stearic acid and linoleic acid
  • alcohols such as e.g. glycerol and ethanol
  • organic acids such as e.g. acetic acid
  • Organic nitrogen-containing compounds such as peptones, yeast extract, meat extract, malt extract, corn steep liquor, soya bean flour and urea
  • inorganic compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate, can be used as the source of nitrogen.
  • the sources of nitrogen can be used individually or as a mixture.
  • Phosphoric acid, potassium dihydrogen phosphate or dipotassiu hydrogen phosphate or the corresponding sodium- containing salts can be used as the source of phosphorus.
  • the culture medium must furthermore comprise salts of metals, such as e.g. magnesium sulfate or iron sulfate, which are necessary for growth.
  • essential growth substances such as amino acids and vitamins, can be employed in addition to the abovementioned substances.
  • Suitable precursors can moreover be added to the culture medium.
  • the starting substances mentioned can be added to the culture in the form of a single batch, or can be fed in during the culture in a suitable manner.
  • Basic compounds such as sodium hydroxide, potassium hydroxide, ammonia or aqueous ammonia, or acid compounds, such as phosphoric acid or sulfuric acid, can be employed in a suitable manner to control the pH of the culture.
  • Antifoams such as e.g. fatty acid polyglycol esters, can be employed to control the development of foam.
  • Suitable substances having a selective action e.g. antibiotics, can be added to the medium to maintain the stability of plasmids .
  • oxygen or oxygen-containing gas mixtures such as e.g. air, are introduced into the culture.
  • the temperature of the culture is usually 25 e C to 45 2 C, and preferably 30 a C to 40 S C. Culturing is continued until a maximum of L-amino acids or L-threonine has formed. This target is usually reached within 10 hours to 160 hours.
  • L-amino acids can be carried out by anion exchange chromatography with subsequent ninhydrin derivation, as described by Spackman et al. (Analytical Chemistry 30: 1190-1206 (1958), or it can take place by reversed phase HPLC as described by Lindroth et al. (Analytical Chemistry 51: 1167-1174 (1979)).
  • the process according to the invention is used for the fermentative preparation of L-amino acids, such as, for example, L-threonine, L-isoleucine, L-valine, L-methionine, L-homoserine and L-lysine, in particular L-threonine.
  • L-amino acids such as, for example, L-threonine, L-isoleucine, L-valine, L-methionine, L-homoserine and L-lysine, in particular L-threonine.
  • the minimal (M9) and complete media (LB) for Escherichia coli used are described by J.H. Miller (A Short Course in Bacterial Genetics (1992), Cold Spring Harbor Laboratory Press) .
  • the isolation of plasmid DNA from Escherichia coli and all techniques of restriction, ligation, Klenow and alkaline phosphatase treatment are carried out by the method of Sambrook et al . (Molecular Cloning - A Laboratory Manual (1989) Cold Spring Harbor Laboratory Press) . Unless described otherwise, the transformation of Escherichia coli is carried out by the method of Chung et al. (Proceedings of the National Academy of Sciences of the United States of America (1989) 86: 2172-2175).
  • the incubation temperature for the preparation of strains and transformants is 37 S C.
  • the ahpC and ahpF genes from E. coli K12 are amplified using the polymerase chain reaction (PCR) and synthetic oligonucleotides .
  • PCR polymerase chain reaction
  • the sequences of the primers are modified such that recognition sites for restriction enzymes are formed.
  • the recognition sequence for Xbal is chosen for the ahpCFl primer and the recognition sequence for Hindlll for the ahpCF2 primer, which are marked by underlining in the nucleotide sequence shown below:
  • ahpCFl 5 ⁇ - GCATCTAGACGATAACACGGAGGAAG - 3 ⁇ (SEQ ID No . 1)
  • ahpCF2 5 ⁇ - GCTAAGCTTTTGCAGGTGAATC - 3 ⁇ (SEQ ID No. 2)
  • the chromosomal E. coli K12 MG1655 DNA employed for the PCR is isolated according to the manufacturer's instructions with "Qiagen Genomic-tips 100/G" (QIAGEN, Hilden, Germany) .
  • a DNA fragment approx. 2400 bp in size can be amplified with the specific primers under standard PCR conditions (Innis et al . (1990) PCR Protocols. A Guide to Methods and Applications, Academic Press) with Pfu-DNA polymerase (Promega Corporation, Madison, USA) .
  • the PCR product is cleaved with the restriction enzymes Xbal and Hindlll and ligated with the vector pTrc99A (Pharmacia Biotech, Uppsala, Sweden) , which has been digested with the enzymes Xbal and Hindlll.
  • the E. coli strain XLl-Blue MRF X (Stratagene, La Jolla, USA) is transformed with the ligation batch and plasmid-carrying cells are selected on LB agar, to which 50 ⁇ g/ml ampicillm are added. Successful cloning can be demonstrated after plasmid DNA isolation by control cleavage with the enzymes EcoRI and Mlul.
  • the plasmid is called pTrc99AahpCF (figure 1) .
  • the L-threonine-producing E. coli strain MG442 is described in the patent specification US-A- 4,278,765 and deposited as CMIM B-1628 at the Russian National Collection for Industrial Microorganisms (VKPM, Moscow, Russia) .
  • the strain MG442 is transformed with the expression plasmid pTrc99AahpCF described in example 1 and with the vector pTrc99A and plasmid-carrying cells are selected on LB agar with 50 ⁇ g/ml ampicillm.
  • the strains MG442/pTrc99AahpCF and MG442/pTrc99A are formed in this manner.
  • Selected individual colonies are then multiplied further on minimal medium with the following composition: 3.5 g/1 Na 2 HP0 4 *2H0, 1.5 g/1 KH 2 P0 4 , 1 g/1 NH 4 C1, 0.1 g/1 MgS0 4 *7H 2 0, 2 g/1 glucose, 20 g/1 agar, 50 mg/1 ampicillm.
  • the formation of L-threonine is checked in batch cultures of 10 ml contained in 100 ml conical flasks.
  • 10 ml of preculture medium of the following composition: 2 g/1 yeast extract, 10 g/1 (NH 4 ) 2 S0, 1 g/1 KH 2 P0 4 , 0.5 g/1 MgS0 4 *7H 2 0, 15 g/1 CaC0 3 , 20 g/1 glucose, 50 mg/1 ampicillm are inoculated and the batch is incubated for 16 hours at 37 a C and 180 rpm on an ESR incubator from Kuhner AG (Birsfelden, Switzerland) .
  • 250 ⁇ l portions of this preculture are transinoculated into 10 ml of production medium (25 g/1 (NH 4 ) 2 S0 4 , 2 g/1 KH 2 P0 , 1 g/1 MgS0 4 *7H 2 0, 0.03 g/1 FeS0 4 *7H 2 0, 0.018 g/1 MnS0 4 *lH 2 0, 30 g/1 CaC0 3 , 20 g/1 glucose, 50 mg/1 ampicillin) and the batch is incubated for 48 hours at 3 2 C.
  • the formation of L-threonine by the starting strain MG442 is investigated in the same manner, but no addition of ampicillin to the medium takes place.
  • the optical density (OD) of the culture suspension is determined with an LP2W photometer from Dr. Lange (D ⁇ sseldorf, Germany) at a measurement wavelength of 660 nm.
  • the concentration of L-threonine formed is then determined in the sterile-filtered culture supernatant with an amino acid analyzer from Eppendorf-BioTronik (Hamburg, Germany) by ion exchange chromatography and post-column reaction with ninhydrin detection.
  • Figure 1 Map of the plasmid pTrc99AahpCF containing the ahpC and ahpF genes .
  • the length data are to be understood as approx. data.
  • the abbreviations and designations used have the following meaning:

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne un procédé de préparation de L-aminoacides, et notamment de L-thréonine.
PCT/EP2002/006560 2001-07-06 2002-06-14 Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees WO2003004663A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US10/481,746 US7172883B2 (en) 2001-07-06 2002-06-14 Process for L-amino acid production using Enterobacteriaceae by enhancing ahpC or ahpF encoding alkyl hydroperoxide reductase
EP02730294A EP1404821B1 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
DE60234444T DE60234444D1 (de) 2001-07-06 2002-06-14 Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae
AT02730294T ATE449167T1 (de) 2001-07-06 2002-06-14 Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae
DK02730294.2T DK1404821T3 (da) 2001-07-06 2002-06-14 Fremgangsmåde til fremstilling af L-aminosyrer under avnendelse af stammer fra familien Enterobacteriaceae
AU2002302642A AU2002302642A1 (en) 2001-07-06 2002-06-14 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10132946.6 2001-07-06
DE10132946A DE10132946A1 (de) 2001-07-06 2001-07-06 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobactericeae
US30379001P 2001-07-10 2001-07-10
US60/303,790 2001-07-10

Publications (2)

Publication Number Publication Date
WO2003004663A2 true WO2003004663A2 (fr) 2003-01-16
WO2003004663A3 WO2003004663A3 (fr) 2003-07-24

Family

ID=26009659

Family Applications (9)

Application Number Title Priority Date Filing Date
PCT/EP2002/006565 WO2003004598A2 (fr) 2001-07-06 2002-06-14 Methode de preparation de l-acides amines mettant en oeuvre des souches de la famille des enterobacteries
PCT/EP2002/006561 WO2003004669A2 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
PCT/EP2002/006563 WO2003004670A2 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-amino acides au moyen de souches de la famille enterobacteriaceae
PCT/EP2002/006566 WO2003004665A2 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-amino acides au moyen de souches de la famille enterobacteriaceae
PCT/EP2002/006564 WO2003004664A2 (fr) 2001-07-06 2002-06-14 Methode de preparation de l-acides amines mettant en oeuvre des souches de la famille des enterobacteries
PCT/EP2002/006568 WO2003004675A2 (fr) 2001-07-06 2002-06-14 Procede destine a la preparation de l-acides amines au moyen de brins de la famille enterobacteriaceae
PCT/EP2002/006562 WO2003004674A2 (fr) 2001-07-06 2002-06-14 Procede de preparation d'acides amines l par utilisation de souches de la famille des enterobacteriaceae
PCT/EP2002/006560 WO2003004663A2 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
PCT/EP2002/006567 WO2003004671A2 (fr) 2001-07-06 2002-06-14 Procede de fabrication de l-acides amines au moyen de souches de la famille des enterobacteriacees

Family Applications Before (7)

Application Number Title Priority Date Filing Date
PCT/EP2002/006565 WO2003004598A2 (fr) 2001-07-06 2002-06-14 Methode de preparation de l-acides amines mettant en oeuvre des souches de la famille des enterobacteries
PCT/EP2002/006561 WO2003004669A2 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
PCT/EP2002/006563 WO2003004670A2 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-amino acides au moyen de souches de la famille enterobacteriaceae
PCT/EP2002/006566 WO2003004665A2 (fr) 2001-07-06 2002-06-14 Procede de preparation de l-amino acides au moyen de souches de la famille enterobacteriaceae
PCT/EP2002/006564 WO2003004664A2 (fr) 2001-07-06 2002-06-14 Methode de preparation de l-acides amines mettant en oeuvre des souches de la famille des enterobacteries
PCT/EP2002/006568 WO2003004675A2 (fr) 2001-07-06 2002-06-14 Procede destine a la preparation de l-acides amines au moyen de brins de la famille enterobacteriaceae
PCT/EP2002/006562 WO2003004674A2 (fr) 2001-07-06 2002-06-14 Procede de preparation d'acides amines l par utilisation de souches de la famille des enterobacteriaceae

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/006567 WO2003004671A2 (fr) 2001-07-06 2002-06-14 Procede de fabrication de l-acides amines au moyen de souches de la famille des enterobacteriacees

Country Status (9)

Country Link
US (4) US20050054066A1 (fr)
EP (9) EP1404858B1 (fr)
AT (8) ATE383436T1 (fr)
AU (8) AU2002316982A1 (fr)
CA (1) CA2453008C (fr)
DE (7) DE60228961D1 (fr)
DK (2) DK1404838T3 (fr)
ES (4) ES2262815T3 (fr)
WO (9) WO2003004598A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004669A3 (fr) * 2001-07-06 2003-07-24 Degussa Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
US7211415B2 (en) 2003-04-09 2007-05-01 Degussa Ag Enterobacteriaceae strains over-expressing the yfiD gene for the fermentative production of L-amino acids
US7575905B2 (en) 2004-02-06 2009-08-18 Evonik Degussa Gmbh Process for L-amino acid production using enterobacteriaceae strains with enhanced yibD
US7638313B2 (en) 2003-01-30 2009-12-29 Degussa Ag Processes for the fermentative preparation of L-threonine using strains of Escherichia in which the yjgF gene is inactivated

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030054503A1 (en) * 2001-04-03 2003-03-20 Degussa Ag Process for the production of L-amino acids using strains of the family enterobacteriaceae that contain an attenuated dgsA gene
DE10132945A1 (de) * 2001-07-06 2003-01-16 Degussa Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae
US7981833B2 (en) * 2004-03-31 2011-07-19 Nippon Shokubai Co., Ltd. Aqueous-liquid-absorbing agent and its production process
DE102004037572A1 (de) * 2004-08-03 2006-02-23 Degussa Ag Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae
DE102005018835A1 (de) 2005-04-22 2006-11-02 Degussa Ag Verfahren zur Herstellung von L-Aminosäuren unter Verwendung verbesserter Stämme der Familie Enterobacteriaceae
EP1899472B1 (fr) * 2005-06-20 2017-09-27 Archer-Daniels-Midland Company Shunt glyoxylique modifie destine a une production amelioree d'acides amines et de produits chimiques derives de l'aspartate
EP1929029A1 (fr) * 2005-09-27 2008-06-11 Ajinomoto Co., Inc. Bacterie produisant un amino acide l et procede de production d'amino acides l
WO2007037459A1 (fr) * 2005-09-27 2007-04-05 Ajinomoto Co., Inc. Bacterie produisant un amino acide l et procede de production d'amino acides l
JP2007185184A (ja) 2005-12-16 2007-07-26 Ajinomoto Co Inc Ｌ−アミノ酸生産菌及びｌ−アミノ酸の製造法
EP1979486B1 (fr) 2006-01-30 2013-04-17 Ajinomoto Co., Inc. Bacterie produisant un acide l-amine et procede de production d'acide l-amine
JP2010017082A (ja) 2006-10-10 2010-01-28 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
JP2010041920A (ja) 2006-12-19 2010-02-25 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
JP2010088301A (ja) 2007-02-01 2010-04-22 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
JP2010110216A (ja) 2007-02-20 2010-05-20 Ajinomoto Co Inc Ｌ−アミノ酸または核酸の製造方法
DE102007051024A1 (de) 2007-03-05 2008-09-11 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae
JP2010130899A (ja) 2007-03-14 2010-06-17 Ajinomoto Co Inc Ｌ−グルタミン酸系アミノ酸生産微生物及びアミノ酸の製造法
EP1975241A1 (fr) 2007-03-29 2008-10-01 Evonik Degussa GmbH Procédé de fabrication d'aminoacides L en utilisant des troncs améliorés de la famille des enterobacteriaceae
DE102007044134A1 (de) 2007-09-15 2009-03-19 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
DE102007052270A1 (de) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
EP2060636A1 (fr) 2007-11-14 2009-05-20 Evonik Degussa GmbH Procédé de fabrication d'acides aminés L en utilisant des souches de la famille des Enterobacteriaceae améliorées
EP2098597A1 (fr) 2008-03-04 2009-09-09 Evonik Degussa GmbH Procédé de fabrication d'aminoacides L en utilisant des troncs améliorés de la famille des enterobacteriaceae
DE102008002309A1 (de) 2008-06-09 2009-12-10 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
DE102008044768A1 (de) 2008-08-28 2010-03-04 Evonik Degussa Gmbh Verfahren zur Herstellung von organisch-chemischen Verbindungen unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
EP2267145A1 (fr) 2009-06-24 2010-12-29 Evonik Degussa GmbH Procédé de fabrication d'aminoacides L en utilisant des troncs améliorés de la famille des enterobacteriaceae
ES2790661T3 (es) 2011-02-09 2020-10-28 Kyowa Hakko Bio Co Ltd Método para producir una sustancia diana mediante un procedimiento de fermentación
AR086790A1 (es) 2011-06-29 2014-01-22 Metabolic Explorer Sa Un microorganismo para la produccion de metionina con importacion de glucosa mejorada
ES2632170T3 (es) * 2012-06-18 2017-09-11 Evonik Degussa Gmbh Microorganismo recombinante para la producción fermentativa de metionina
KR101773755B1 (ko) 2013-05-13 2017-09-01 아지노모토 가부시키가이샤 Ｌ-아미노산의 제조법
JP2016165225A (ja) 2013-07-09 2016-09-15 味の素株式会社 有用物質の製造方法
EP2886651B1 (fr) 2013-10-21 2018-08-22 Ajinomoto Co., Inc. Procédé de production d'un acide aminé de forme l
JP6519476B2 (ja) 2013-10-23 2019-05-29 味の素株式会社 目的物質の製造法
JP6623690B2 (ja) 2015-10-30 2019-12-25 味の素株式会社 グルタミン酸系ｌ−アミノ酸の製造法
JP2017192325A (ja) * 2016-04-19 2017-10-26 三菱ケミカル株式会社 有機酸の製造方法
JP7066977B2 (ja) 2017-04-03 2022-05-16 味の素株式会社 Ｌ－アミノ酸の製造法
US11053526B2 (en) 2018-08-09 2021-07-06 Evonik Operations Gmbh Process for preparing L amino acids using improved strains of the enterobacteriaceae family
EP3608409A1 (fr) 2018-08-09 2020-02-12 Evonik Operations GmbH Procédé de préparation d'acides aminés l au moyen de souches améliorées de la famille des enterobacteriaceae
EP3861109A1 (fr) 2018-10-05 2021-08-11 Ajinomoto Co., Inc. Procédé de production d'une substance cible par fermentation bactérienne
EP4239070A1 (fr) 2020-10-28 2023-09-06 Ajinomoto Co., Inc. Procédé de production d'acide l-aminé
US20240117393A1 (en) 2022-09-30 2024-04-11 Ajinomoto Co., Inc. Method for producing l-amino acid

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU875663A1 (ru) * 1978-06-30 1982-09-15 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Штаммы е.coLI ВНИИГенетика VL 334 @ N6 и ВНИИГенетика VL 334 @ N7-продуценты L-треонина и способ их получени
JPS55131397A (en) * 1979-04-02 1980-10-13 Ajinomoto Co Inc Preparation of l-threonine by fermentation
JPS5685289A (en) 1979-12-13 1981-07-11 Ajinomoto Co Inc Preparation of l-valine by fermentation
US5705371A (en) * 1990-06-12 1998-01-06 Ajinomoto Co., Inc. Bacterial strain of escherichia coli BKIIM B-3996 as the producer of L-threonine
US6132999A (en) * 1992-09-21 2000-10-17 Ajinomoto Co., Inc. L-threonine-producing microbacteria and a method for the production of L-threonine
US5807735A (en) * 1995-03-29 1998-09-15 Exxon Research And Engineering Company Solvent-resistant microorganisms
EP0827542B1 (fr) * 1995-05-05 2008-04-09 Genencor International, Inc. Application de mutants de transport du glucose a la production de composes a voie aromatique
US5939307A (en) * 1996-07-30 1999-08-17 The Archer-Daniels-Midland Company Strains of Escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production
JP4088982B2 (ja) * 1996-10-15 2008-05-21 味の素株式会社 発酵法によるｌ−アミノ酸の製造法
US6372457B1 (en) * 1997-01-14 2002-04-16 Arkion Life Sciences Llc Process and materials for production of glucosamine
DE19831609B4 (de) 1997-10-04 2009-11-12 Evonik Degussa Gmbh Verfahren zur Herstellung von Aminosäuren der Aspartat- und/oder Glutamatfamilie und im Verfahren einsetzbare Mittel
US6068991A (en) * 1997-12-16 2000-05-30 Bristol-Myers Squibb Company High expression Escherichia coli expression vector
US6159738A (en) * 1998-04-28 2000-12-12 University Of Chicago Method for construction of bacterial strains with increased succinic acid production
RU2144564C1 (ru) * 1998-10-13 2000-01-20 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" ФРАГМЕНТ ДНК rhtB, КОДИРУЮЩИЙ СИНТЕЗ БЕЛКА RhtB, ПРИДАЮЩЕГО УСТОЙЧИВОСТЬ К L-ГОМОСЕРИНУ БАКТЕРИЯМ ESCHERICHIA COLI, И СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ
RU2148642C1 (ru) 1998-12-23 2000-05-10 ЗАО "Научно-исследовательский институт АДЖИНОМОТО-Генетика" (ЗАО "АГРИ") Фрагмент днк rhtc, кодирующий синтез белка rhtc, придающего повышенную устойчивость к l-треонину бактериям escherichia coli, и способ получения l-аминокислоты
JP2003204788A (ja) 1999-07-19 2003-07-22 Ajinomoto Co Inc 発酵法による目的物質の製造法
DE19947792A1 (de) * 1999-10-05 2001-04-12 Degussa Neue für das Irp Gen codierende Nukleotidsequenzen
DE10001101A1 (de) * 2000-01-13 2001-07-19 Degussa Neue für das ptsH-Gen codierende Nukleotidsequenzen
CA2400777A1 (fr) 2000-05-27 2001-12-06 Degussa Ag Procede de preparation par fermentation de l-threonine
AU2001265969A1 (en) 2000-07-18 2002-01-30 Degussa A.G. Process for the fermentative preparation of l-threonine
DE10045496A1 (de) * 2000-09-14 2002-03-28 Degussa Neue für das ptsi-Gen kodierende Nukleotidsequenzen
DE10046623A1 (de) * 2000-09-20 2002-03-28 Degussa Neue für das dps-Gen kodierende Nukleotidsequenzen
DE10113011A1 (de) * 2001-03-17 2002-09-19 Degussa Verfahren zur fermentativen Herstellun von L-Aminosäuren unter Verwendung coryneforme Bakterien
JP2002330763A (ja) * 2001-05-02 2002-11-19 Ajinomoto Co Inc 発酵法による目的物質の製造法
DE10128780A1 (de) * 2001-06-13 2002-12-19 Degussa Verfahren zur fermentativen Herstellung von D-Pantothensäure und/oder deren Salzen
DE10132945A1 (de) * 2001-07-06 2003-01-16 Degussa Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae
EP1404858B1 (fr) * 2001-07-06 2008-01-09 Evonik Degussa GmbH Procede destine a la preparation de l-acides amines au moyen de brins de la famille i enterobacteriaceae /i

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004669A3 (fr) * 2001-07-06 2003-07-24 Degussa Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
WO2003004664A3 (fr) * 2001-07-06 2003-07-31 Degussa Methode de preparation de l-acides amines mettant en oeuvre des souches de la famille des enterobacteries
WO2003004670A3 (fr) * 2001-07-06 2003-07-31 Degussa Procede de preparation de l-amino acides au moyen de souches de la famille enterobacteriaceae
WO2003004665A3 (fr) * 2001-07-06 2003-08-21 Degussa Procede de preparation de l-amino acides au moyen de souches de la famille enterobacteriaceae
WO2003004674A3 (fr) * 2001-07-06 2003-08-28 Degussa Procede de preparation d'acides amines l par utilisation de souches de la famille des enterobacteriaceae
WO2003004671A3 (fr) * 2001-07-06 2003-09-18 Degussa Procede de fabrication de l-acides amines au moyen de souches de la famille des enterobacteriacees
WO2003004675A3 (fr) * 2001-07-06 2003-09-18 Degussa Procede destine a la preparation de l-acides amines au moyen de brins de la famille enterobacteriaceae
WO2003004598A3 (fr) * 2001-07-06 2003-12-18 Degussa Methode de preparation de l-acides amines mettant en oeuvre des souches de la famille des enterobacteries
US7638313B2 (en) 2003-01-30 2009-12-29 Degussa Ag Processes for the fermentative preparation of L-threonine using strains of Escherichia in which the yjgF gene is inactivated
US7211415B2 (en) 2003-04-09 2007-05-01 Degussa Ag Enterobacteriaceae strains over-expressing the yfiD gene for the fermentative production of L-amino acids
US7575905B2 (en) 2004-02-06 2009-08-18 Evonik Degussa Gmbh Process for L-amino acid production using enterobacteriaceae strains with enhanced yibD

Also Published As

Publication number Publication date
ATE334220T1 (de) 2006-08-15
EP1404857A2 (fr) 2004-04-07
AU2002316982A1 (en) 2003-01-21
EP1404836A2 (fr) 2004-04-07
WO2003004671A3 (fr) 2003-09-18
WO2003004670A2 (fr) 2003-01-16
CA2453008A1 (fr) 2003-01-16
WO2003004674A3 (fr) 2003-08-28
WO2003004671A2 (fr) 2003-01-16
EP1404838B1 (fr) 2010-03-31
EP1404836B1 (fr) 2008-11-26
EP1404837A2 (fr) 2004-04-07
EP1404821A2 (fr) 2004-04-07
US7172883B2 (en) 2007-02-06
ATE449167T1 (de) 2009-12-15
EP1404839A2 (fr) 2004-04-07
AU2002316983A1 (en) 2003-01-21
ATE462790T1 (de) 2010-04-15
US7241600B2 (en) 2007-07-10
AU2002319229A1 (en) 2003-01-21
EP1404821B1 (fr) 2009-11-18
US20040241813A1 (en) 2004-12-02
AU2002302642A1 (en) 2003-01-21
DK1404821T3 (da) 2010-03-22
CA2453008C (fr) 2011-03-22
US20050106687A1 (en) 2005-05-19
AU2002345038A1 (en) 2003-01-21
EP1404838A2 (fr) 2004-04-07
WO2003004669A3 (fr) 2003-07-24
ES2343944T3 (es) 2010-08-13
WO2003004598A2 (fr) 2003-01-16
ATE383436T1 (de) 2008-01-15
DE60210772T2 (de) 2007-04-12
DE60234444D1 (de) 2009-12-31
WO2003004669A2 (fr) 2003-01-16
ATE323778T1 (de) 2006-05-15
EP1404835A2 (fr) 2004-04-07
WO2003004598A3 (fr) 2003-12-18
ES2318022T3 (es) 2009-05-01
EP1404858B1 (fr) 2008-01-09
DE60230040D1 (de) 2009-01-08
ES2336655T3 (es) 2010-04-15
AU2002316984A1 (en) 2003-01-21
DE60235810D1 (de) 2010-05-12
ATE415478T1 (de) 2008-12-15
EP1404856A2 (fr) 2004-04-07
US20050069993A1 (en) 2005-03-31
WO2003004675A2 (fr) 2003-01-16
EP1404857B1 (fr) 2006-04-19
ATE408691T1 (de) 2008-10-15
DK1404838T3 (da) 2010-07-12
WO2003004674A2 (fr) 2003-01-16
EP1404856B1 (fr) 2006-07-26
ATE417107T1 (de) 2008-12-15
AU2002314169A1 (en) 2003-01-21
WO2003004665A3 (fr) 2003-08-21
WO2003004663A3 (fr) 2003-07-24
EP1404837B1 (fr) 2008-12-10
AU2002314168A1 (en) 2003-01-21
WO2003004665A2 (fr) 2003-01-16
WO2003004664A3 (fr) 2003-07-31
US20050054066A1 (en) 2005-03-10
ES2262815T3 (es) 2006-12-01
DE60228961D1 (de) 2008-10-30
WO2003004670A3 (fr) 2003-07-31
DE60230274D1 (de) 2009-01-22
WO2003004675A3 (fr) 2003-09-18
WO2003004664A2 (fr) 2003-01-16
EP1404835B1 (fr) 2008-09-17
DE60224536D1 (de) 2008-02-21
DE60210772D1 (de) 2006-05-24
DE60224536T2 (de) 2009-01-08
EP1404858A2 (fr) 2004-04-07

Similar Documents

Publication Publication Date Title
EP1404821B1 (fr) Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
EP1407024B1 (fr) Procede de preparation de l-threonine a l'aide de souches de la famille des enterobacteriacees contenant un gene phoe renforce
US20090226985A1 (en) Process for the Preparation of L-Amino Acids Using Strains of the Enterobacteriaceae Family
US20050118689A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
US20040241814A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced rsea or rsec gene
EP1483387B1 (fr) Procede de preparation de l-threonine au moyen de souches de la famille enterobacteriaceae

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG US

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002730294

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10481746

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002730294

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载